Key result
MMP-7 overexpression linked to higher tumor stage and lymph node metastasis in resected esophageal cancer.
Observational (n=61)
Increased mRNA expression of MMP-7, MMP-10, and TIMP-1 correlates with clinicopathologic features in resected esophageal cancer, suggesting a role in disease progression.
Should not yet change esophageal cancer management; leaves open MMP-7 as a hypothesis-generating prognostic marker.
INTRODUCTION: Tissue inhibitors of metalloproteinases (TIMP) and the matrix metalloproteinases (MMP) are involved in the spread of cancer. METHODS: We have evaluated the matrix metalloproteinases' (MMP-10, MMP-7) and their inhibitors' (tissue inhibitors of metalloproteinases - TIMP-1, TIMP-2) mRNA expression in 61 esophageal cancer samples from patients who had undergone surgery, by using real-time quantitative RT-PCR, and correlated the results with the patient clinicopathologic features. RESULTS: MMP-10, MMP-7, TIMP-1, TIMP-2 were overexpressed in 73%, 85%, 55% and 42% of esophageal cancer samples, respectively. The expression of MMP-10, TIMP-1, and TIMP-2 correlated with the tumor size. The MMP-7 overexpression was associated with the tumour stage (I, II vs III, p=0.05) and lymph node metastasis (N0 vs N1, p=0.037). CONCLUSIONS: We conclude that in the resected esophageal cancer an increased mRNA expression of MMP-7, MMP-10 and TIMP-1 correlated with clinicopathologic features. We suggest that these genes may play a role during progression of the disease.
No takes yet. Share an insight, caveat, or question.
Juchniewicz et al. (2017) conducted an observational in Esophageal cancer (n=61). MMP-10, MMP-7, TIMP-1, and TIMP-2 mRNA expression was evaluated on Correlation of mRNA expression with clinicopathologic features. MMP-7 overexpression in resected esophageal cancer was associated with higher tumor stage (p=0.05) and lymph node metastasis (p=0.037).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: